provides general information regarding cytisine

Quit Smoking with Tabex
Sopharma Shop

March 1 (Reuters) – Oncogenex Pharmaceuticals Inc

* Oncogenex Pharma says Achieve Life Science and co announce strategic collaboration with National Institutes of Health to advance development of cytisine

* Oncogenex Pharmaceuticals Inc says results of initial study are expected in second-quarter of 2017

* Oncogenex Pharmaceuticals Inc says multiple key cytisine development and regulatory milestones expected in 2017 Source text for Eikon: Further company coverage: